Navigation Links
Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
Date:11/19/2012

trategic Alliance Focused Primarily on Metabolic Diseases.  In August 2012, Regulus entered into a strategic alliance with AstraZeneca AB ("AZ") to discover, develop, and commercialize microRNA therapeutics for three exclusive targets focused on cardiovascular and metabolic diseases and oncology.  AZ made an upfront payment of $3.0 million and purchased $25.0 million of Regulus' common stock in a private placement that closed concurrently with the IPO. In addition, Regulus is eligible to receive preclinical, clinical and commercialization milestone payments of up to $509.0 million, as well as royalties. 
  • Established Research Collaboration to Explore microRNA Biomarkers for Multiple Sclerosis.  In August 2012, Regulus formed a collaboration with Biogen Idec Inc. ("Biogen Idec") to explore microRNA biomarkers for multiple sclerosis.  Regulus received an upfront payment of $750,000 and is eligible to receive milestone payments of up to $1.3 million.  Regulus also received $5.0 million from the sale of a convertible note to Biogen Idec which converted into shares of Regulus' common stock at the closing of the IPO. 
  • Re-Aligned Board of Directors.  In November 2012, Douglas E. Williams, Ph.D., Executive Vice President of Research and Development at Biogen Idec, joined Regulus' Board of Directors.  Concurrently, Stanley T. Crooke, M.D., Ph.D., Chairman of the Board and CEO of Isis Pharmaceuticals, Inc., and Barry E. Greene, President and Chief Operating Officer of Alnylam Pharmaceuticals, Inc., stepped down from the Board and their respective Board committees. 
  • Third Quarter 2012 Financial Results & HighlightsAs of September 30, 2012, Regulus had cash, cash equivalents and short-term investments of $30.9 million compared to $38.1 million at December 31, 2011.  The decrease in cash, cash equivalents and short-term investments was the result of approximately $17.7 m
    '/>"/>

    SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
    2. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
    3. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
    4. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
    5. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
    6. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
    7. Grupo Casa Saba Reports - Grupo Casa Saba Announces its Intention to Delist From the New York Stock Exchange
    8. Solos Endoscopy Reports Book Value of $2,393,522 for Period Ended September 30, 2012
    9. ULURU Inc. Reports Third Quarter 2012 Financial Results
    10. Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2012 Results
    11. China Pharma Holdings, Inc. Reports Third Quarter 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held ... into an exclusive distributor agreement with ITOCHU Corporation (Tokyo ... therapy system for the treatment of cancer in ... system, is the world,s first and only MRI-guided radiation ...
    (Date:1/22/2015)... (NASDAQ: AMGN ) today announced that it will report ... Jan. 27, 2015, after the close of the U.S. financial markets. ... investment community at 2 p.m. PT. Participating in the call from ... executive officer, and other members of Amgen,s senior management team. ...
    (Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/x3hp3g/microbiology ... "Microbiology Testing/Clinical Microbiology Market by Product, Clinical Application ... report to their offering. Clinical ... for the detection of infectious diseases. The respiratory ...
    Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 3
    (Date:1/22/2015)... York (PRWEB) January 22, 2015 The federal ... in the U.S. District Court, Southern District of West Virginia ... Inc. in that proceeding’s first bellwether trial. In an Order ... a new trial after finding that C.R. Bard had not ...
    (Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
    (Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
    (Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
    (Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
    Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
    ... certain diseases could be provided by creating drugs which change ... published today in the journal Nature Reviews Drug Discovery. , ... the human gut. They play a key role in many ... people have different types of gut microbes living inside them ...
    ... all too frequent, but preventable, and urges better pediatric ... events (IEs) -- unintended harm or suffering caused by ... hospitals, according to new French research. , These IEs ... at La Conception Hospital in Marseille, France. , They ...
    ... Calif., Feb. 1 Lifespring Health,sponsors the Kaiser Permanente ... an important charity event benefiting the Hemophilia Foundation of,Northern ... Koret Family House., Set to take place on ... 13.1 mile course is ranked as one of the ...
    ... is not only joy and goodwill that,epitomise Christmas and the ... not least, drinking and partying., This can be one ... alcohol,issues: office parties, family parties, neighbours, parties; it goes on ... days and broken,promises. For some the merriment of Christmas and ...
    ... Jan. 31 We may all want to ... health, it,s actually better to be,regular. Here,s more ... daily fiber we,need., Listen to this report ... , Registered journalists can access video, audio, ...
    ... study finds many aren,t getting preventive treatments , , ... half the patients in hospitals worldwide risk developing ... many aren,t receiving treatments that could prevent the ... thromboembolism has long been recognized to be one ...
    Cached Medicine News:Health News:Targeting gut bugs could revolutionize future drugs, say researcher 2Health News:Unintended Errors Leave Many Newborns Vulnerable 2Health News:A Festive White Knuckle Ride? 2Health News:Hospital Patients' Blood Clot Risk High 2Health News:Hospital Patients' Blood Clot Risk High 3
    ... membrane switch control, solid cast aluminum ... button folding armrests, multi-position full range ... with handle, ergonomically contoured cushions with ... choice of upholstery colors. Optional features: ...
    Fixed chair back and armrests, electric lift with 8" (20.3cm) stroke, foot pedal control, choice of upholstery colors. Optional features: 15 tilt mechanism and footrest, locking rotation, sliding arm...
    ... can support patient's full weight. Footstep tilts out ... Patients may be raised and lowered by either ... back or optional corded foot switch. Dual rotation ... you to swivel the chair 330 without changing ...
    Heine Beta 200 Streak Retinoscope 3.5v w/Twist Lock for Welch-Allyn style handles....
    Medicine Products: